Geode Capital Management, LLC Timber Pharmaceuticals, Inc. Transaction History

Geode Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.1 - $0.3 $54,775 - $164,325	547,750 Added 228.87%	787,079 $94,000
Q2 2022 Aug 12, 2022	BUY	$0.24 - $0.39 $8,066 - $13,107	33,609 Added 16.34%	239,329 $75,000
Q1 2022 May 13, 2022	SELL	$0.28 - $0.41 $57 - $84	-207 Reduced 0.1%	205,720 $79,000
Q3 2021 Nov 12, 2021	BUY	$0.89 - $1.18 $37,460 - $49,666	42,090 Added 25.69%	205,927 $187,000
Q2 2021 Aug 13, 2021	BUY	$1.06 - $2.25 $142,896 - $303,318	134,808 Added 464.39%	163,837 $199,000
Q1 2021 May 12, 2021	BUY	$0.81 - $3.55 $23,513 - $103,052	29,029 New	29,029 $58,000

Ticker TMBR
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 146,524,992
Description
Timber Pharmaceuticals LLC, a clinical-stage biopharmaceutical company, engages in the development and commercialization of treatments for orphan dermatologic diseases. The company's lead product candidates include TMB-001, a patented topical formulation of isotretinoin that has completed Phase 2b clinical trial for the treatment of moderate to ...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.